A PYMNTS Company

US: Senate Dems call for antitrust investigation of EpiPen maker

By  |  September 6, 2016

Senate Democrats are calling on federal regulators to investigate whether the manufacturer of EpiPen violated antitrust laws when it allegedly required schools to sign noncompete contracts.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    In a letter Tuesday, Sens. Richard Blumenthal and Amy Klobuchar asked the Federal Trade Commission to issue Mylan an administrative subpoena to determine whether the company deliberately engaged in exclusionary practices to hinder its competitors and maintain its monopoly position in the market.

    The lawmakers said there’s a document that seems to confirm press reports that Mylan required schools participating in its “EpiPen4Schools” discount program to sign exclusive contracts stipulating the schools would “not in the next twelve months purchase any products that are competitive to EpiPen Auto-Injectors.”

    They believe the contracts violate Section 5 of the Federal Trade Commission Act, which bans unfair methods of competition, and possibly Section 2 the Sherman Act, which prohibits attempts to acquire or maintain a monopoly.

    Full Content: The Hill

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.